MaaT Pharma Completes a Capital Increase of approximately €12.7 Million with the Support of Current Shareholders-Seventure etc (February 17, 2023) | By Maat Pharma SA. MaaT Pharma Completes a Capital Increase of approximately €12.7 Million with the Support of Current Shareholders Lyon, France, February 17, 2023, 7:30 am CET – MaaT Pharma (EURONEXT: MAAT –
Merck hands Swedish biotech €10M cash to develop anti-inflammatory drugs (February 16, 2023) | By Katherine Lewin, News Reporter. Merck is betting on Aqilion’s work on a small molecule inhibitor for autoimmune and inflammatory diseases, including neurological diseases. Merck is paying €10 million upfront cash to the Swedish-based biotech in a licensing deal and research collaboration
Summary – The microbial world has been a rich source of medicines, but our ability to explore the full potential of the microbes both in us and around us has been limited by technology and the difficulty of culturing most microbes in a lab. Biosortia Microbiomics has developed a platform for finding, amplifying, and screening microbes as a potential source of novel, small-molecule drugs.
By Ross Youngs, February 2, 2023. 12 QUESTIONS to ChatGPT MICROBIOME DISCOVERY Chat GPT from OpenAI is a new and interesting way of interrogating the universe of data online and formulating it into a cohesive human communication format. To prove the point that this will be part of the next generations of human efficiency improvement that
